Cirius Therapeutics has a total of 31 patents globally, out of which 24 have been granted. Of these 31 patents, more than 83% patents are active. New Zealand is where Cirius Therapeutics has filed the maximum number of patents, followed by Hungary and Austria. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Cirius Therapeutics.
Cirius Therapeutics was founded in the year 2015. The Company operates as a pharmaceutical company. The Company develops insulin sensitizer for the treatment of non-alcoholic steatohepatitis.
Do read about some of the most popular patents of Cirius Therapeutics which have been covered by us in this article and also you can find Cirius Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cirius Therapeutics patent portfolio.
How many patents does Cirius Therapeutics have?
Cirius Therapeutics has a total of 31 patents globally. These patents belong to 5 unique patent families. Out of 31 patents, 26 patents are active.
How Many Patents did Cirius Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Cirius Therapeutics Applications Filed | Cirius Therapeutics Patents Granted |
2017 | – | 9 |
2016 | – | 6 |
2015 | – | 2 |
2014 | – | 1 |
2013 | – | 4 |
2012 | – | 2 |
2011 | 18 | – |
2010 | 11 | – |
2008 | 2 | – |
How many Cirius Therapeutics patents are Alive/Dead?
How Many Patents did Cirius Therapeutics File in Different Countries?
Countries in which Cirius Therapeutics Filed Patents
Country | Patents |
New Zealand | 6 |
Hungary | 3 |
Austria | 3 |
Germany | 3 |
Norway | 3 |
Denmark | 3 |
Poland | 3 |
Europe | 3 |
Spain | 3 |
Korea (South) | 1 |
Where are Research Centres of Cirius Therapeutics Patents Located?
List of Cirius Therapeutics Patents
Cirius Therapeutics Patents | Title |
EP2512470B1 | Ppar-Sparing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases |
EP2603498B1 | Novel Synthesis For Thiazolidinedione Compounds |
EP2560956B1 | Novel Synthesis For Thiazolidinedione Compounds |
NZ606574B | Novel Synthesis For Thiazolidinedione Compounds |
NZ602883B | Novel Synthesis For Thiazolidinedione Compounds |
NZ600390B | Ppar-Sparing Thiazolidinedione Salts For The Treatment Of Metabolic Diseases |
NZ597381B | Thiazolidinedione Analogues For The Treatment Of Hypertension |
NZ583889B | Thiazolidinedione Analogues For The Treatment Of Hypertension |
PL2603498T3 | Novel Synthesis For Thiazolidinedione Compounds |
PL2512470T3 | Ppar-Sparing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases |
ES2617704T3 | Ppar-Sparing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases |
ES2610623T3 | Novel Synthesis For Thiazolidinedione Compounds |
ES2609837T3 | Novel Synthesis For Thiazolidinedione Compounds |
PL2560956T3 | Novel Synthesis For Thiazolidinedione Compounds |
DK2560956T3 | Hitherto Unknown Synthesis Of Thiazolidine Dione Compounds |
DK2603498T3 | Hitherto Unknown Synthesis Of Thiazolidine Dione Compounds |
DE602011032206T2 | Novel Synthesis For Thiazolidedione Compounds |
DE602011031654T2 | Novel Synthesis For Thiazolidedione Compounds |
NO2603498B1 | Novel Synthesis For Thiazolidinedione Compounds |
NO2560956B1 | Novel Synthesis For Thiazolidinedione Compounds |
NO2512470B1 | Ppar-Sparing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases |
HUE033199T2 | Ppar-Sparing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases |
HUE031424T2 | Novel Synthesis For Thiazolidinedione Compounds |
HUE030263T2 | Novel Synthesis For Thiazolidinedione Compounds |
AT839905T | Novel Synthesis Of Thiazolidinedione Compounds |
AT843783T | Novel Synthesis Of Thiazolidinedione Compounds |
NZ600421B | Ppar-Sparing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases |
DK2512470T3 | Ppar-Sparing Thiazolide Diones And Combinations For The Treatment Of Neurodegenerated Diseases |
DE602010038493T2 | Ppar-Immediate Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases |
AT849152T | Ppar-Bypassing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases |
KR1020120103711A | Ppar-Sparing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases |
What are Cirius Therapeutics key innovation segments?
What Technologies are Covered by Cirius Therapeutics?
The chart below distributes patents filed by Cirius Therapeutics